相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Infiltrating CD8+T cells and M2 macrophages are retained in tumor matrix tracks enriched in low tension fibronectin fibers
Charlotte M. Fonta et al.
MATRIX BIOLOGY (2023)
CAR-T Cells in the Treatment of Ovarian Cancer: A Promising Cell Therapy
Xi-Wen Zhang et al.
Biomolecules (2023)
Tumor-associated macrophages in cancer: recent advancements in cancer nanoimmunotherapies
Nisha Kumari et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)
Targeting cancer-associated fibroblast-secreted WNT2 restores dendritic cell-mediated antitumour immunity
Tu-Xiong Huang et al.
GUT (2022)
Dual inhibition of TGF-β and PD-L1: a novel approach to cancer treatment
James L. Gulley et al.
MOLECULAR ONCOLOGY (2022)
Mesothelial cell-derived antigen-presenting cancer-associated fibroblasts induce expansion of regulatory T cells in pancreatic cancer
Huocong Huang et al.
CANCER CELL (2022)
CXCR2 inhibition enables NASH-HCC immunotherapy
Jack Leslie et al.
GUT (2022)
Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy
Yangfu Jiang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)
Modulating tenascin-C functions by targeting the MAtrix REgulating MOtif, MAREMO
Thomas Loustau et al.
MATRIX BIOLOGY (2022)
A decade of checkpoint blockade immunotherapy in melanoma: understanding the molecular basis for immune sensitivity and resistance
Alexander C. Huang et al.
NATURE IMMUNOLOGY (2022)
Metabolic reprogramming of tumor-associated macrophages by collagen turnover promotes fibrosis in pancreatic cancer
Madeleine M. LaRue et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
Identification of Functional Heterogeneity of Carcinoma-Associated Fibroblasts with Distinct IL6-Mediated Therapy Resistance in Pancreatic Cancer
Kathleen M. McAndrews et al.
CANCER DISCOVERY (2022)
Transforming Growth Factor-Beta (TGF-β) Signaling in Cancer-A Betrayal Within
Abdul Basit Baba et al.
FRONTIERS IN PHARMACOLOGY (2022)
Coordinated Regulation of Myeloid-Derived Suppressor Cells by Cytokines and Chemokines
Ru Li et al.
CANCERS (2022)
Comprehensive Analysis on Prognosis and Immune Infiltration of Lysyl Oxidase Family Members in Pancreatic Adenocarcinoma With Experimental Verification
Chao Jiang et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2022)
Cancer-associated fibroblasts in breast cancer: Challenges and opportunities
Dengdi Hu et al.
CANCER COMMUNICATIONS (2022)
DDR1 functions as an immune negative factor in colorectal cancer by regulating tumor-infiltrating T cells through IL-18
Xiaofan Duan et al.
CANCER SCIENCE (2022)
Pan-cancer single-cell analysis reveals the heterogeneity and plasticity of cancer-associated fibroblasts in the tumor microenvironment
Han Luo et al.
NATURE COMMUNICATIONS (2022)
Temporal profiling of the breast tumour microenvironment reveals collagen XII as a driver of metastasis
Michael Papanicolaou et al.
NATURE COMMUNICATIONS (2022)
Hypoxia induces HIF1α-dependent epigenetic vulnerability in triple negative breast cancer to confer immune effector dysfunction and resistance to anti-PD-1 immunotherapy
Shijun Ma et al.
NATURE COMMUNICATIONS (2022)
The Desmoplastic Stroma of Pancreatic Cancer: Multilayered Levels of Heterogeneity, Clinical Significance, and Therapeutic Opportunities
Yohei Masugi
CANCERS (2022)
The UIP/IPF fibroblastic focus is a collagen biosynthesis factory embedded in a distinct extracellular matrix
Jeremy A. Herrera et al.
JCI INSIGHT (2022)
Targeting the tumor stroma for cancer therapy
Maosen Xu et al.
MOLECULAR CANCER (2022)
LRRC15+ myofibroblasts dictate the stromal setpoint to suppress tumour immunity
Akshay T. Krishnamurty et al.
NATURE (2022)
Spatial Positioning and Matrix Programs of Cancer-Associated Fibroblasts Promote T-cell Exclusion in Human Lung Tumor
John A. Grout et al.
CANCER DISCOVERY (2022)
Culprits of PDAC resistance to gemcitabine and immune checkpoint inhibitor: Tumour microenvironment components
Sheng-Kai Hsu et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2022)
Cytotoxic CD8+T cells in cancer and cancer immunotherapy
Hans Raskov et al.
BRITISH JOURNAL OF CANCER (2021)
Tumor-associated macrophages in immunotherapy
Shijia Yan et al.
FEBS JOURNAL (2021)
Comparison between the first-line and second-line immunotherapy drugs in the progression-free survival and overall survival in advanced non-small cell lung cancer: a systematic review and meta-analysis of randomized controlled trials
Shengyu Wu et al.
ANNALS OF PALLIATIVE MEDICINE (2021)
Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives
Xiaoqi Mao et al.
MOLECULAR CANCER (2021)
Tumour DDR1 promotes collagen fibre alignment to instigate immune exclusion
Xiujie Sun et al.
NATURE (2021)
Interferon-γ induces tumor resistance to anti-PD-1 immunotherapy by promoting YAP phase separation
Man Yu et al.
MOLECULAR CELL (2021)
T cells in pancreatic cancer stroma
Michelle R. Goulart et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2021)
Macrophages and Extracellular Matrix in Breast Cancer: Partners in Crime or Protective Allies?
Claire Deligne et al.
FRONTIERS IN ONCOLOGY (2021)
Tenascin-C immobilizes infiltrating T lymphocytes through CXCL12 promoting breast cancer progression
Devadarssen Murdamoothoo et al.
EMBO MOLECULAR MEDICINE (2021)
Interplay between Cellular and Non-Cellular Components of the Tumour Microenvironment in Hepatocellular Carcinoma
Tamas Suekei et al.
CANCERS (2021)
Cancer-Associated Fibroblasts Promote the Upregulation of PD-L1 Expression Through Akt Phosphorylation in Colorectal Cancer
Yang Gao et al.
FRONTIERS IN ONCOLOGY (2021)
Tumor Associated Macrophages: Origin, Recruitment, Phenotypic Diversity, and Targeting
Tetiana Hourani et al.
FRONTIERS IN ONCOLOGY (2021)
An Integrated Fibrosis Signature for Predicting Survival and Immunotherapy Efficacy of Patients With Hepatocellular Carcinoma
Long Liu et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2021)
Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy
Zhaonian Hao et al.
BIOMARKER RESEARCH (2021)
Tumor hypoxia is associated with resistance to PD-1 blockade in squamous cell carcinoma of the head and neck
Dan P. Zandberg et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Tumor Immune Microenvironment and Immunosuppressive Therapy in Hepatocellular Carcinoma: A Review
Kyoko Oura et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Profiling Cancer-Associated Fibroblasts in Melanoma
Federica Papaccio et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Targeting HIF-1 alpha transcriptional activity drives cytotoxic immune effector cells into melanoma and improves combination immunotherapy
Audrey Lequeux et al.
ONCOGENE (2021)
Abundant intratumoral fibrosis prevents lymphocyte infiltration into peritoneal metastases of colorectal cancer
En Wang et al.
PLOS ONE (2021)
Targeting cancer associated fibroblasts to enhance immunotherapy: emerging strategies and future perspectives
Christopher J. Hanley et al.
Oncotarget (2021)
Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment
Alba Nicolas-Boluda et al.
ELIFE (2021)
Tumor-Associated Macrophages in Pancreatic Ductal Adenocarcinoma: Therapeutic Opportunities and Clinical Challenges
Ashleigh R. Poh et al.
CANCERS (2021)
Single-cell analysis of pancreatic ductal adenocarcinoma identifies a novel fibroblast subtype associated with poor prognosis but better immunotherapy response
Yu Wang et al.
CELL DISCOVERY (2021)
The Tumor Microenvironment Factors That Promote Resistance to Immune Checkpoint Blockade Therapy
Bonnie L. Russell et al.
FRONTIERS IN ONCOLOGY (2021)
Fibroblasts as immune regulators in infection, inflammation and cancer
Sarah Davidson et al.
NATURE REVIEWS IMMUNOLOGY (2021)
Turning cold tumors into hot tumors by improving T-cell infiltration
Yuan-Tong Liu et al.
THERANOSTICS (2021)
Biological bases of cancer immunotherapy
Maryanne M. Gonzales Carazas et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2021)
The matrix in cancer
Thomas R. Cox
NATURE REVIEWS CANCER (2021)
Extracellular Matrix Remodeling and Development of Cancer
Koyeli Girigoswami et al.
STEM CELL REVIEWS AND REPORTS (2021)
Cancer-associated fibroblasts in desmoplastic tumors: emerging role of integrins
Cedric Zeltz et al.
SEMINARS IN CANCER BIOLOGY (2020)
Conjunction junction, what's the function? CCN proteins as targets in fibrosis and cancers
Andrew Leask
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2020)
A review of cancer immunotherapy toxicity
Lucy Boyce Kennedy et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
NOX4 Inhibition Potentiates Immunotherapy by Overcoming Cancer-Associated Fibroblast-Mediated CD8 T-cell Exclusion from Tumors
Kirsty Ford et al.
CANCER RESEARCH (2020)
Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma
Jia-qiao Fan et al.
MOLECULAR CANCER (2020)
Hyperprogression and Immune Checkpoint Inhibitors: Hype or Progress?
Jacob J. Adashek et al.
ONCOLOGIST (2020)
Fibrosis and cancer: A strained relationship
Bram Piersma et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)
Yap suppresses T-cell function and infiltration in the tumor microenvironment
Eleni Stampouloglou et al.
PLOS BIOLOGY (2020)
Matrix-Targeting Immunotherapy Controls Tumor Growth and Spread by Switching Macrophage Phenotype
Claire Deligne et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Burden of tumor mutations, neoepitopes, and other variants are weak predictors of cancer immunotherapy response and overall survival
Mary A. Wood et al.
GENOME MEDICINE (2020)
The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses
Alireza Labani-Motlagh et al.
FRONTIERS IN IMMUNOLOGY (2020)
Pancreatic cancer stroma: an update on therapeutic targeting strategies
Abdel N. Hosein et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
The Resistance Mechanisms of Checkpoint Inhibitors in Solid Tumors
Evangelos Koustas et al.
BIOMOLECULES (2020)
Desmoplasia and Biophysics in Pancreatic Ductal Adenocarcinoma Can We Learn From Breast Cancer?
Francesco Di Maggio et al.
PANCREAS (2020)
Tenascin-C Orchestrates an Immune-Suppressive Tumor Microenvironment in Oral Squamous Cell Carcinoma
Caroline Spenle et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Redefining Tumor-Associated Macrophage Subpopulations and Functions in the Tumor Microenvironment
Kaiyue Wu et al.
FRONTIERS IN IMMUNOLOGY (2020)
Surmounting the obstacles that impede effective CAR T cell trafficking to solid tumors
Emmanuel Donnadieu et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2020)
The tumor microenvironment
Nicole M. Anderson et al.
CURRENT BIOLOGY (2020)
T cells in COVID-19-united in diversity
Leo Swadling et al.
NATURE IMMUNOLOGY (2020)
Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8+ T cell exhaustion
David H. Peng et al.
NATURE COMMUNICATIONS (2020)
Immune Remodeling of the Extracellular Matrix Drives Loss of Cancer Stem Cells and Tumor Rejection
Ana Pires et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Cancer-associated fibroblasts an their influence on tumor immunity and immunotherapy
Richard Lee Barrett et al.
ELIFE (2020)
Tumor-Associated Macrophages in Tumor Immunity
Yueyun Pan et al.
FRONTIERS IN IMMUNOLOGY (2020)
Transforming Growth Factor-β Signaling in Fibrotic Diseases and Cancer-Associated Fibroblasts
Xueke Shi et al.
BIOMOLECULES (2020)
TGF-β inhibition combined with cytotoxic nanomedicine normalizes triple negative breast cancer microenvironment towards anti-tumor immunity
Myrofora Panagi et al.
THERANOSTICS (2020)
A review of cancer immunotherapy: from the past, to the present, to the future
K. Esfahani et al.
CURRENT ONCOLOGY (2020)
A framework for advancing our understanding of cancer-associated fibroblasts
Erik Sahai et al.
NATURE REVIEWS CANCER (2020)
A guide to cancer immunotherapy: from T cell basic science to clinical practice
Alex D. Waldman et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Remodeling the fibrotic tumor microenvironment of desmoplastic melanoma to facilitate vaccine immunotherapy
Hongda Zhu et al.
NANOSCALE (2020)
CD8+ T cell states in human cancer: insights from single-cell analysis
Anne M. Van der Leun et al.
NATURE REVIEWS CANCER (2020)
Extracellular Matrix in the Tumor Microenvironment and Its Impact on Cancer Therapy
Erik Henke et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
Killing Mechanisms of Chimeric Antigen Receptor (CAR) T Cells
Mohamed-Reda Benmebarek et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
CYR61/CCN1 Regulates dCK and CTGF and Causes Gemcitabine-resistant Phenotype in Pancreatic Ductal Adenocarcinoma
Gargi Maity et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Blocking CXCR4 alleviates desmoplasia, increases T-lymphocyte infiltration, and improves immunotherapy in metastatic breast cancer
Ivy X. Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
The double edge sword of fibrosis in cancer
Chelsea Chandler et al.
TRANSLATIONAL RESEARCH (2019)
Cancer associated fibroblasts sculpt tumour microenvironment by recruiting monocytes and inducing immunosuppressive PD-1+ TAMs
Betul Gokyavuz et al.
SCIENTIFIC REPORTS (2019)
Collagen density regulates the activity of tumor-infiltrating T cells
Dorota E. Kuczek et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Current Challenges in Cancer Immunotherapy: Multimodal Approaches to Improve Efficacy and Patient Response Rates
Manpreet Sambi et al.
JOURNAL OF ONCOLOGY (2019)
Stroma in normal and cancer wound healing
Eric Huet et al.
FEBS JOURNAL (2019)
HIF-1α Is a Metabolic Switch between Glycolytic-Driven Migration and Oxidative Phosphorylation-Driven Immunosuppression of Tregs in Glioblastoma
Jason Miska et al.
CELL REPORTS (2019)
Anticancer Immunotherapy by MFAP5 Blockade Inhibits Fibrosis and Enhances Chemosensitivity in Ovarian and Pancreatic Cancer
Tsz-Lun Yeung et al.
CLINICAL CANCER RESEARCH (2019)
The Emerging Role of YAP/TAZ in Tumor Immunity
Zhaoji Pan et al.
MOLECULAR CANCER RESEARCH (2019)
Poly-ICLC, a TLR3 Agonist, Induces Transient Innate Immune Responses in Patients With Treated HIV-Infection: A Randomized Double-Blinded Placebo Controlled Trial
Mansi Saxena et al.
FRONTIERS IN IMMUNOLOGY (2019)
Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy
Tongyan Liu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
The clinical role of the TME in solid cancer
Nicolas A. Giraldo et al.
BRITISH JOURNAL OF CANCER (2019)
Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape
Xianjie Jiang et al.
MOLECULAR CANCER (2019)
Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti-CTLA-4 antibody
Danbee Ha et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
The Intriguing History of Cancer Immunotherapy
Paula Dobosz et al.
FRONTIERS IN IMMUNOLOGY (2019)
CAF Subpopulations: A New Reservoir of Stromal Targets in Pancreatic Cancer
Brooke A. Pereira et al.
TRENDS IN CANCER (2019)
Hypoxia as a barrier to immunotherapy in pancreatic adenocarcinoma
S. K. Daniel et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2019)
Current Progress in CAR-T Cell Therapy for Solid Tumors
Shuo Ma et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2019)
Integrins in wound healing, fibrosis and tumor stroma: High potential targets for therapeutics and drug delivery
Jonas Schnittert et al.
ADVANCED DRUG DELIVERY REVIEWS (2018)
Cancer-Associated Fibroblasts Affect Intratumoral CD8+ and FoxP3+ T Cells Via IL6 in the Tumor Microenvironment
Takuya Kato et al.
CLINICAL CANCER RESEARCH (2018)
The fibrotic tumor stroma
Mitsuo Yamauchi et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Activation of cancer-associated fibroblasts is required for tumor neovascularization in a murine model of melanoma
James Hutchenreuther et al.
MATRIX BIOLOGY (2018)
YAP Is Essential for Treg-Mediated Suppression of Antitumor Immunity
Xuhao Ni et al.
CANCER DISCOVERY (2018)
Talimogene laherparepvec: First in class oncolytic virotherapy
Robert M. Conry et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
Tissue-Dependent Tumor Microenvironments and Their impact on immunotherapy Responses
Amanda J. Oliver et al.
FRONTIERS IN IMMUNOLOGY (2018)
Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, efficacy, and Limitations
Judith A. Seidel et al.
FRONTIERS IN ONCOLOGY (2018)
Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy
Priyamvada Jayaprakash et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Reactive Oxygen Species as Regulators of MDSC-Mediated Immune Suppression
Kim Ohl et al.
FRONTIERS IN IMMUNOLOGY (2018)
Immunotherapy and Prevention of Pancreatic Cancer
Alexander H. Morrison et al.
TRENDS IN CANCER (2018)
CD4+ T cell help in cancer immunology and immunotherapy
Jannie Borst et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Significance of Intratumoral Fibrosis in Clear Cell Renal Cell Carcinoma
Jae Won Joung et al.
JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE (2018)
Recombinant human granulocyte macrophage colony stimulating factor (hGM-CSF): Possibility of nanoparticle-mediated delivery in cancer immunotherapy
Selvarajan Vanitha et al.
BIOENGINEERED (2017)
Integrin-targeted cancer immunotherapy elicits protective adaptive immune responses
Byron H. Kwan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Fibrotic focus: An important parameter for accurate prediction of a high level of tumor-associated macrophage infiltration in invasive ductal carcinoma of the breast
Hiroko Shimada et al.
PATHOLOGY INTERNATIONAL (2017)
Towards integrating extracellular matrix and immunological pathways
David F. Boyd et al.
CYTOKINE (2017)
Hippo effector YAP directly regulates the expression of PD-L1 transcripts in EGFR-TKI-resistant lung adenocarcilloma
Byung Soo Lee et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Tumor-associated fibrosis as a regulator of tumor immunity and response to immunotherapy
Hong Jiang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
Immunotherapy for Breast Cancer: What Are We Missing?
Robert H. Vonderheide et al.
CLINICAL CANCER RESEARCH (2017)
The emerging role of ECM crosslinking in T cell mobility as a hallmark of immunosenescence in humans
Jean-Francois Moreau et al.
AGEING RESEARCH REVIEWS (2017)
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Padmanee Sharma et al.
CELL (2017)
Tumor macrophages are pivotal constructors of tumor collagenous matrix
Ran Afik et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy
Hong Jiang et al.
NATURE MEDICINE (2016)
Pegylated Interferon α-2a Triggers NK-Cell Functionality and Specific T-Cell Responses in Patients with Chronic HBV Infection without HBsAg Seroconversion
Juliana Bruder Costa et al.
PLOS ONE (2016)
Desmoplasia in Primary Tumors and Metastatic Lesions of Pancreatic Cancer
Clifford J. Whatcott et al.
CLINICAL CANCER RESEARCH (2015)
Imiquimod - Its role in the treatment of cutaneous malignancies
Aditya Kumar Bubna
INDIAN JOURNAL OF PHARMACOLOGY (2015)
Spatial organization of the tenascin-C microenvironment in experimental and human cancer
Caroline Spenle et al.
CELL ADHESION & MIGRATION (2015)
Immune Escape Mechanisms as a Guide for Cancer Immunotherapy
Gregory L. Beatty et al.
CLINICAL CANCER RESEARCH (2015)
tTregs, pTregs, and iTregs: similarities and differences
Ethan M. Shevach et al.
IMMUNOLOGICAL REVIEWS (2014)
Hypoxia and the extracellular matrix: drivers of tumour metastasis
Daniele M. Gilkes et al.
NATURE REVIEWS CANCER (2014)
Matricellular proteins: priming the tumour microenvironment for cancer development and metastasis
G. S. Wong et al.
BRITISH JOURNAL OF CANCER (2013)
Tumor-associated macrophages and stromal TNF-α regulate collagen structure in a breast tumor model as visualized by second harmonic generation
Ryan M. Burke et al.
JOURNAL OF BIOMEDICAL OPTICS (2013)
Targeting CXCL12 from FAP-expressing carcinomaassociated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer
Christine Feig et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Cancer-associated fibroblasts as targets for immunotherapy
Sunitha Kakarla et al.
IMMUNOTHERAPY (2012)
Desmoplasia: A Response or a Niche?
Yves A. DeClerck
CANCER DISCOVERY (2012)
The role of the myofibroblast in tumor stroma remodeling
Marcela Otranto et al.
CELL ADHESION & MIGRATION (2012)
Aligned Collagen Is a Prognostic Signature for Survival in Human Breast Carcinoma
Matthew W. Conklin et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Matrix Metalloproteinases in Cytotoxic Lymphocytes Impact on Tumour Infiltration and Immunomodulation
Karin Edsparr et al.
CANCER MICROENVIRONMENT (2011)
Regulatory T cells: immune suppression and beyond
Yisong Y. Wan
CELLULAR & MOLECULAR IMMUNOLOGY (2010)
Tumors as Organs: Complex Tissues that Interface with the Entire Organism
Mikala Egeblad et al.
DEVELOPMENTAL CELL (2010)
How do Regulatory T Cells Work?
A. Corthay
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2009)
Galectin-1 functions as a Th2 cytokine that selectively induces Th1 apoptosis and promotes Th2 function
Claudia C. Motran et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Cellular and molecular mechanisms of fibrosis
T. A. Wynn
JOURNAL OF PATHOLOGY (2008)
Hypoxia and cancer
M. Christiane Brahimi-Horn et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2007)
Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-β signals in vivoi
ML Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Distinct IL-2 receptor signaling pattern in CD4+CD25+ regulatory T cells
SJ Bensinger et al.
JOURNAL OF IMMUNOLOGY (2004)
Pegylated interferon alfa-2b treatment for patients with solid tumors: A phase I/II study
R Bukowski et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Highly proliferative fibroblasts forming fibrotic focus govern metastasis of invasive ductal carcinoma of the breast
T Hasebe et al.
MODERN PATHOLOGY (2001)
Proliferative activity of intratumoral fibroblasts is closely correlated with lymph node and distant organ metastases of invasive ductal carcinoma of the breast
T Hasebe et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)